Updated Jul 16, 2026
Slosman Marvin has filed 2 SEC Form 4 filings across 2 companies in the last 90 days — buying. Lifetime open-market purchases: $50K.
Marvin Slosman is the CEO and President of InspireMD, Inc., a medical device company specializing in vascular and coronary disease treatments. He has also served as a Director for the company, contributing to its focus on proprietary MicroNet stent technology.
| Role | Director |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-13 | NSPR | InspireMD, Inc. | P — Open-market purchase | 21.0K | $1.20 | $25K |
| 2026-01-16 | NSPR | InspireMD, Inc. | A — Grant or award | 1.11M | $0.00 | |
| 2025-07-30 | NSPR | InspireMD, Inc. | P — Open-market purchase | 10.3K | $2.42 | $25K |
Marvin Slosman is the CEO and President of InspireMD, Inc., a medical device company specializing in vascular and coronary disease treatments. He has also served as a Director for the company, contributing to its focus on proprietary MicroNet stent technology.…
2 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 2 open-market purchases ($50K) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Slosman Marvin profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.